Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction

Overview of attention for article published in Blood Advances, April 2025

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 8 X users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 13,654 followers.

Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Initial Response to Intensive Chemotherapy Induction https://t.co/GtzFb0KmwP

RT @ZhuoerXie: #WisdomWednesday Patients with AML and an IDH2-R172 Mutation Exhibit a Unique Initial Response to Intensive Chemotherapy In…

Whoa this is interesting and not something that I had previously considered @MartinTallman https://t.co/PsKqFUkuca

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.